}
Partner With Us
Advertisement

Jennifer Ford, senior managing editor



Newtonsoft.Json.Linq.JArray;
thumb description 3/1/2024 5:00:00 AM;

March 01, 2024

Study Published of RadiusXR VR Perimetry Platform

Results show a 0.94 correlation in mean deviation and statistical noninferiority to traditional methods for staging glaucoma.

Category: [ "Clinical Guidelines" ]

Specialty: [ "Ophthalmology", "Neurology" ]

Publication: Glaucoma Physician

thumb description 7/1/2023 8:00:00 AM;

July 01, 2023

Eylea HD 8-mg Injection Approved for Wet AMD, DME, and DR

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Category: [ "FDA & Government News" ]

Specialty: [ "Ophthalmology", "Internal Medicine" ]

Publication: Retinal Physician

thumb description 7/1/2024 4:00:00 AM;

July 01, 2024

Interim Phase 1 HELIOS Trial Data of Axpaxli for NPDR Presented at ASRS

At the 2024 meeting of the American Society of Retina Specialists in Stockholm, Dilsher S. Dhoot, MD, presented a late-breaking interim analysis from the HELIOS study of Axpaxli, a sustained-release axitinib implant.

Category: []

Specialty: [ "Ophthalmology", "Endocrinology", "Oncology" ]

Publication: Retinal Physician

thumb description 5/1/2024 4:00:00 AM;

May 01, 2024

Uveitis Corner: Spotlight on Young Uveitis Specialists

The Young Uveitis Specialists (YUS) group is a subsection of the American Uveitis Society (AUS). They are a professional group of early career uveitis specialists and specialists in training. Here, Retinal Physician speaks with founding members Arthi Venkat, MD; Edmund Tsui, MD; Kareem Moussa, MD; Jessica Shantha, MD; and Eric Crowell, MD, about the organization and its goals.

Category: []

Specialty: []

Publication: Retinal Physician

thumb description 12/1/2023 5:00:00 AM;

December 01, 2023

ViaLase Completes Enrollment for Pivotal Trial of Laser for POAG

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Category: []

Specialty: [ "Ophthalmology" ]

Publication: Glaucoma Physician

thumb description 7/1/2023 4:00:00 AM;

July 01, 2023

Iveric Bio's Izervay Receives FDA Approval as Treatment for Geographic Atrophy

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Category: [ "Clinical Guidelines" ]

Specialty: [ "Ophthalmology", "Internal Medicine" ]

Publication: Retinal Physician

thumb description 7/1/2024 4:00:00 AM;

July 01, 2024

Supplemental Injection Data From DAVIO 2 Trial of EYP-1901 Presented at ASRS

At the 2024 meeting of the American Society of Retina Specialists in Stockholm, Veeral S. Sheth, MD, MBA, FASRS, FACS, presented late-breaking data on supplemental injection in the DAVIO 2 trial of Duravyu (EYP-1901; EyePoint Pharmaceuticals).

Category: []

Specialty: [ "Ophthalmology", "Endocrinology", "Oncology" ]

Publication: Retinal Physician

thumb description 4/1/2023 4:00:00 AM;

April 01, 2023

RETINA CONVERSATIONS A Conversation About Optoretinography

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Category: [ "From the Journals" ]

Specialty: [ "Ophthalmology", "Neurology", "Dermatology" ]

Publication: Retinal Physician

Advertisement